Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calyx Ventures Inc.

https://calyxbio.com/

Latest From Calyx Ventures Inc.

Gene Delivery: Looking Past the Skeptics

The criticism of gene therapy has been continual and consistent. But in fact, at least some delivery systems do work. It is true, however, that not all vectors work in all diseases, and the challenge for gene delivery start-ups is figuring out which ones work where.

BioPharmaceutical Business Strategies

Replicor Inc.

Spun-out of McGill University, Replicor is modulating DNA replication for better gene therapies and to influence cell proliferation for cancer or tissue engineering.

BioPharmaceutical
See All

Company Information

  • Industry
  • Diversified
  • Other Names / Subsidiaries
    • Cannigistics Agri-Solutions Corp
    • Calyx Bio-Ventures Inc.
    • Chromos Molecular Systems Inc.
UsernamePublicRestriction

Register